Mannitol Dosing for Increased Intracranial Pressure
Standard Dosing Recommendations
- The American Academy of Pediatrics recommends administering mannitol 0.25-1 g/kg IV over 20-30 minutes for treating increased intracranial pressure, with 0.25 g/kg being as effective as higher doses for acute ICP reduction while minimizing risks of osmotic complications 1, 2, 3
- For acute intracranial hypertensive crisis, a dose of 0.5-1 g/kg over 15 minutes may be appropriate 1, 2, 3
- In pediatric patients, a dose of 1-2 g/kg or 30-60 g/m² body surface area over 30-60 minutes is recommended 1, 2, 3
Administration Protocol
- The American Academy of Pediatrics suggests placing a urinary catheter before administration due to osmotic diuresis 1, 2, 3
- Administer mannitol through a filter and do not use solutions containing crystals 1, 2, 3
- The standard infusion rate is over 20-30 minutes 1, 2, 3, 4
- In cases of acute crisis, infusion over 15 minutes for larger doses may be appropriate 1, 2, 3
Monitoring Requirements
- The American Academy of Pediatrics recommends maintaining serum osmolality below 320 mOsm/L and discontinuing mannitol if serum osmolality exceeds 320 mOsm/L to prevent renal failure 4, 5
- Monitor fluid, sodium, and chloride balance 5
- Maintain cerebral perfusion pressure (CPP) between 60-70 mmHg during treatment 4, 5
Multimodal ICP Management
- The American Academy of Pediatrics recommends using mannitol in conjunction with other ICP control measures, such as hyperventilation, sedation and analgesia, head-of-bed elevation, cerebrospinal fluid drainage, barbiturates, and neuromuscular blockade 1, 2, 3, 5
Alternative: Hypertonic Saline
- The American College of Critical Care Medicine suggests that at equiosmotic doses, mannitol and hypertonic saline have comparable efficacy for ICP reduction 4, 5
- Choose hypertonic saline when hypovolemia or hypotension is present 4, 5
- Choose mannitol when hypernatremia exists or improved cerebral blood flow rheology is desired 5
Critical Clinical Caveats
- The American Heart Association recommends avoiding the use of mannitol in hypotension or hypovolemia, and considering hypertonic saline instead 4
- Mannitol can cause rebound intracranial hypertension, particularly with prolonged use or rapid discontinuation, especially when serum osmolality rises excessively 5
- In children, mannitol may worsen intracranial hypertension by increasing cerebral blood flow if generalized cerebral hyperemia develops within 24-48 hours post-injury 5